Advertisement
Advertisement
October 25, 2024
Vantis CrossFast Microcatheter Guide Extension System Cleared by FDA
October 25, 2024—Vantis Vascular, Inc. announced it has received FDA 510(k) clearance for its CrossFast integrated microcatheter guide extension system.
According to the company, the dual monorail microcatheter system is designed for complex coronary and peripheral interventions. The device is powered by Vantis Vascular’s DuoPro interlocking technology, a mechanism that couples the outer and inner extension catheters.
The CrossFast system will be commercially available in the United States in Q4 2024 as part of a limited market release, with a full market release planned in 2025, advised the company.
Advertisement
Advertisement